Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Floor A. C. Berden"'
Autor:
Daan W. Von den Hoff, Floor A. C. Berden, Joost P. H. Drenth, Arnt F. A. Schellekens, HepNed, NISPA
Publikováno v:
Addiction Science & Clinical Practice, Vol 17, Iss 1, Pp 1-7 (2022)
Abstract Background People who use drugs (PWUD) are at high risk for hepatitis C virus (HCV) infection and its complications. Given the high prevalence rate of HCV in PWUD, the World Health Organization (WHO) emphasizes PWUD as a target population fo
Externí odkaz:
https://doaj.org/article/5512f6b01f404c8f8571d739aec06c77
Autor:
Floor A C Berden, Robert J de Knegt, Hans Blokzijl, Sjoerd D Kuiken, Karel J L van Erpecum, Sophie B Willemse, Jan den Hollander, Marit G A van Vonderen, Pieter Friederich, Bart van Hoek, Carin M J van Nieuwkerk, Joost P H Drenth, Wietske Kievit
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0161821 (2016)
BACKGROUND:Approval of drugs in chronic hepatitis C is supported by registration trials. These trials might have limited generalizability through use of strict eligibility criteria. We compared effectiveness and safety of real world hepatitis C patie
Externí odkaz:
https://doaj.org/article/df63fcc0640b409ebc0d1424a0973708
Autor:
Daan W. Von den Hoff, Floor A. C. Berden, Femke Atsma, Arnt F. A. Schellekens, Joost P. H. Drenth
Publikováno v:
Journal of Clinical Medicine, 11
Journal of Clinical Medicine; Volume 11; Issue 4; Pages: 1146
Journal of Clinical Medicine, 11, 4
Journal of Clinical Medicine; Volume 11; Issue 4; Pages: 1146
Journal of Clinical Medicine, 11, 4
Contains fulltext : 248103.pdf (Publisher’s version ) (Open Access) The elimination of viral hepatitis in target populations is crucial in reaching WHO viral hepatitis elimination goals. Several barriers for the treatment of viral hepatitis in peop